image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 0.2461
-3.83 %
$ 23.6 M
Market Cap
0.02
P/E
CASH FLOW STATEMENT
-125 M OPERATING CASH FLOW
-0.29%
24.2 M INVESTING CASH FLOW
-70.81%
114 M FINANCING CASH FLOW
394.70%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Bionano Genomics, Inc.
image
Net Income -232 M
Depreciation & Amortization 13.9 M
Capital Expenditures -1.69 M
Stock-Based Compensation 15.2 M
Change in Working Capital -14.8 M
Others 86.7 M
Free Cash Flow -127 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (232.5) (132.6) (72.4) (41.1) (29.8) (18.5) (23.4) (18.8)
Depreciation & Amortization 13.9 9.8 3.4 1.5 1.1 1.3 1.5 1.1
Deferred Income Tax 0 1.8 (5.8) 1.9 1.9 (2.5) 0.5 (3.0)
Stock Based Compensation 15.2 22.4 9.7 1.6 1.3 1.3 0.4 0.1
Other Operating Activities 93.0 2.4 0.8 1.3 0.9 0.8 96.6 K 73.9 K
Change in Working Capital (14.8) (28.6) (7.7) (3.4) (5.0) (2.4) 85.1 K (3.0)
Cash From Operations (125.2) (124.8) (71.9) (38.3) (29.5) (19.9) (20.8) (23.5)
INVESTING CASH FLOW
Capital Expenditures (1.7) (3.3) (1.5) 0 61.1 K (0.3) (1.0) (1.3)
Other Items 25.8 86.1 (276.6) (2.4) 0 0 0 0
Cash From Investing Activities 24.2 82.8 (278.1) (2.4) 61.1 K (0.3) (1.0) (1.3)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 47 K 36 K (15.0) (4.7) 9.8 16.4 0 1.9
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 113.9 85 K 8.4 26.7 1.0 3.5 K 17.6 23.5
Cash From Financing Activities 113.8 23.0 336.1 61.9 30.4 35.8 17.6 25.4
CHANGE IN CASH
Net Change In Cash 12.9 (19.1) (13.9) 21.1 0.8 15.5 (4.2) 0.6
FREE CASH FLOW
Free Cash Flow (126.9) (128.1) (73.4) (38.3) (29.6) (20.3) (21.8) (24.8)